Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.
Jacobson JM, Israel RJ, Lowy I, Ostrow NA, Vassilatos LS, Barish M, Tran DN, Sullivan BM, Ketas TJ, O'Neill TJ, Nagashima KA, Huang W, Petropoulos CJ, Moore JP, Maddon PJ, Olson WC. Jacobson JM, et al. Among authors: petropoulos cj. Antimicrob Agents Chemother. 2004 Feb;48(2):423-9. doi: 10.1128/AAC.48.2.423-429.2004. Antimicrob Agents Chemother. 2004. PMID: 14742190 Free PMC article. Clinical Trial.
Combinations of mutations in the connection domain of human immunodeficiency virus type 1 reverse transcriptase: assessing the impact on nucleoside and nonnucleoside reverse transcriptase inhibitor resistance.
Gupta S, Fransen S, Paxinos EE, Stawiski E, Huang W, Petropoulos CJ. Gupta S, et al. Among authors: petropoulos cj. Antimicrob Agents Chemother. 2010 May;54(5):1973-80. doi: 10.1128/AAC.00870-09. Epub 2010 Mar 1. Antimicrob Agents Chemother. 2010. PMID: 20194692 Free PMC article.
Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition.
Fransen S, Bridger G, Whitcomb JM, Toma J, Stawiski E, Parkin N, Petropoulos CJ, Huang W. Fransen S, et al. Among authors: petropoulos cj. Antimicrob Agents Chemother. 2008 Jul;52(7):2608-15. doi: 10.1128/AAC.01226-07. Epub 2008 Apr 28. Antimicrob Agents Chemother. 2008. PMID: 18443125 Free PMC article. Clinical Trial.
Multiple genetic pathways involving amino acid position 143 of HIV-1 integrase are preferentially associated with specific secondary amino acid substitutions and confer resistance to raltegravir and cross-resistance to elvitegravir.
Huang W, Frantzell A, Fransen S, Petropoulos CJ. Huang W, et al. Among authors: petropoulos cj. Antimicrob Agents Chemother. 2013 Sep;57(9):4105-13. doi: 10.1128/AAC.00204-13. Epub 2013 Jun 3. Antimicrob Agents Chemother. 2013. PMID: 23733474 Free PMC article.
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.
Whitcomb JM, Huang W, Fransen S, Limoli K, Toma J, Wrin T, Chappey C, Kiss LD, Paxinos EE, Petropoulos CJ. Whitcomb JM, et al. Among authors: petropoulos cj. Antimicrob Agents Chemother. 2007 Feb;51(2):566-75. doi: 10.1128/AAC.00853-06. Epub 2006 Nov 20. Antimicrob Agents Chemother. 2007. PMID: 17116663 Free PMC article.
Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.
Coakley E, Reeves JD, Huang W, Mangas-Ruiz M, Maurer I, Harskamp AM, Gupta S, Lie Y, Petropoulos CJ, Schuitemaker H, van 't Wout AB. Coakley E, et al. Among authors: petropoulos cj. Antimicrob Agents Chemother. 2009 Nov;53(11):4686-93. doi: 10.1128/AAC.00229-09. Epub 2009 Aug 17. Antimicrob Agents Chemother. 2009. PMID: 19687240 Free PMC article.
224 results